Home › Core › ISCC-IDs › 28C63Vtifdbzo

View ISCC-ID

Core Data

28C63Vtifdbzo
ISCC-ID - digital asset identifier
CCVo47DKoxwLn-CTUcGoLDmRJuv-CDmTJ4X5DoPsm-CRVDCaVkxxz7e
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

separation of plasma thromboplastin antecedent from kallikrein by the plasma α2macroglobulin kallikrein inhibitor

Ledger Reference

coblo
Source Ledger/Blockchain
12403967
N-th ISCC Decleration on source ledger
45c29f7d77ee4b3c9913d8fcad6e6d8747e9d21346a9149f88fd0683b0e3baa6
Hash of block that includes the ISCC-DECLARATION
2167ea7d82437a7a6a0a9e57b9f25ae881a94867d89d3d46cfdcfee09fecd5d4
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Separation of Plasma Thromboplastin Antecedent from Kallikrein by the Plasma \u03b12-Macroglobulin, Kallikrein Inhibitor", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Peter C. Harpel", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://www.jci.org/articles/view/106702/files/pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Society for Clinical Investigation", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1172/jci106702", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCVo47DKoxwLn-CTUcGoLDmRJuv-CDmTJ4X5DoPsm-CRVDCaVkxxz7e", "propertyID": "ISCC"}], "datePublished": "1971-10-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close